The price of a QC material is easy to see. The costs of limited quality control are not.
Repeat testing, wasted reagents, additional instrument use, lengthy investigations, regulatory challenges, and the impact on patient care can all add up when problems are detected too late. Yet these hidden costs are often overlooked when laboratories evaluate their QC strategy.
This white paper takes a closer look at the true expense of a limited quality control strategy, examining the operational, financial, regulatory, and patient-care consequences that can extend far beyond the QC material itself.
Before cutting QC, take a closer look at what’s at stake.